Question 1

What are the potential side effects of BMS-275183?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies clinical trial (NCT00207025). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies clinical trial (NCT00207025). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my participation involve in terms of visits and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies clinical trial (NCT00207025). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific health conditions that would exclude me from this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies clinical trial (NCT00207025). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to take this treatment if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies clinical trial (NCT00207025). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies clinical trial (NCT00207025). Contact the study team or your healthcare provider for specific answers.

What this study is about